Livestock Pharmaceuticals Industry Global Key Vendors,Manufacturers,Suppliers and Analysis Market Report 2023

WiseGuyReports.Com adds “Livestock Pharmaceuticals Industry Global Key Vendors,Manufacturers,Suppliers and Analysis Market Report 2023” Research to its Database.

Description:

Global Livestock Pharmaceuticals Market:

Market Outline: Global Livestock Pharmaceuticals Market
Livestock pharmaceuticals are used to treat various diseases in animals such as infectious diseases, parasitic diseases, and inflammatory diseases among others. Vaccines are administered to livestock for the prevention of various diseases which increase the immunity of the livestock and makes animal healthy. Livestock pharmaceuticals can be administered as solids or liquids directly to the livestock or some pharmaceuticals can be mixed with the animal feed.

Market Dynamics: Global Livestock Pharmaceuticals Market

Increase in the prevalence of various livestock diseases such as bird flu in poultry, rise in animal welfare expenditure, government initiatives for the animal health management, and rise in demand for healthy meat and other livestock products are anticipated to fuel the livestock pharmaceuticals market. Moreover, rise in disposable income, increase in the awareness about livestock diseases and treatment, and rise in R&D activities for the innovation of newer therapeutics and vaccines might bolster the growth of the market. However, stringent regulatory guidelines for veterinary medicine approval, ban of certain antibiotics used in the animal diseases, poor availability of drugs in the underdeveloped regions, and dearth of skilled veterinary professionals are hampering the growth of the market.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/2753949-livestock-pharmaceuticals-market-global-market-estimation-dynamics-regional-share-trends

For more information or any query mail at sales@wiseguyreports.com

Market Scope: Global Livestock Pharmaceuticals Market
Livestock pharmaceuticals market is segmented on the basis of drug class, disease type, route of administration, livestock type, and distribution channel
Based on the drug class, livestock pharmaceuticals is segmented into the following:
Vaccines
Antivirals
Antibiotics
Parasiticides
Anti-inflammatory drugs
Others

Based on the disease type, livestock pharmaceuticals market is segmented into the following:
Neurological disorders
Infectious diseases
Viral diseases
Bacterial diseases
Fungal diseases
Others

Based on the route of administration, livestock pharmaceuticals market is segmented into the following:
Oral
Parenteral
Topical
Others

Based on the livestock, livestock pharmaceuticals market is segmented into the following:
Poultry
Aquatic Animals
Swine
Equine
Sheep
Cattle
Others

Based on the distribution channel, livestock pharmaceuticals market is segmented into the following:
Veterinary hospitals
Veterinary pharmacies
Online pharmacies

Market Summary: Livestock Pharmaceuticals Market

Livestock pharmaceuticals market growing at a significant CAGR owing to increase in the R&D activities for the innovation of newer drugs for various livestock diseases. Increase in the prevalence of various livestock diseases, rise in demand for healthy meat and other livestock products, increase in the farming of aquatic animals might propel the livestock pharmaceuticals market over the forecast period. Acquisitions & mergers, collaborations, and product launching are the strategies followed by the companies for increasing their revenue share in livestock pharmaceuticals market. For instance, in November 2014, Merck Animal Health launched Finadyne a transdermal non-steroidal anti-inflammatory drug used in cattle for the treatment of pyrexia associated with bovine respiratory disease. In addition, in March 2016, Zoetis Inc. inked an agreement with Sanofi’s Merial unit for diversifying the product portfolio and marketing the vaccines and drugs for dairy cattle in India.

Regional Analysis: Livestock Pharmaceuticals Market

Geographically, livestock pharmaceuticals market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Increase in the R&D activities for the development of newer drugs by several U.S. pharmaceutical companies, rise in awareness about the veterinary diseases and treatment, increase in the animal welfare expenditure, and rise in product approvals for livestock diseases are anticipated to propel the North America livestock pharmaceuticals market. Europe livestock pharmaceuticals market growth driven by rise in the production of aquatic animals in Norway, Denmark, Ireland, and other European countries, increase in the demand for healthy meat and other livestock products, rise in the disposable income, and increase in the prevalence of zoonotic diseases. However, Asia Pacific livestock pharmaceuticals market growing at significant rate owing to increase in population demanding for quality meat, launching of newer drugs in Asia Pacific region, and industrialization of poultry sector in the region.

Market Participants: Livestock Pharmaceuticals Market

Some of the players in livestock pharmaceuticals market are Merck Animal Health (U.S.), Zoetis Inc. (Pfizer) (U.S.), Boehringer Ingelheim (Germany), Ceva Animal Health (France), Bayer Animal Health (Germany), Virbac Inc. (France), Elanco Animal Health (U.S.), Eco Animal Health (U.K.), and Heska Corporation (U.S.) to name a few.
Notable Market Developments: Livestock Pharmaceuticals Market
In July 2017, ECO Animal Health received FDA approval for Aivlosin an antibiotic used in the treatment of major enteric and respiratory diseases in poultry and swine
In March 2017, Merck Animal Health acquired Brazilian company Vallee S.A. for strengthening its livestock pharmaceuticals product portfolio

Ask Query @ https://www.wiseguyreports.com/enquiry/2753949-livestock-pharmaceuticals-market-global-market-estimation-dynamics-regional-share-trends

Table Of Contents – Major Key Points

1. Executive Summary

2. Global Livestock Pharmaceuticals Market Introduction
2.1. Global Livestock Pharmaceuticals Market – Taxonomy
2.2. Global Livestock Pharmaceuticals Market –Definitions
2.2.1. Drug Class
2.2.2. Disease Type
2.2.3. Route of administration
2.2.4. Livestock
2.2.5. Distribution Channel

3. Global Livestock Pharmaceuticals Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Livestock Pharmaceuticals Market Dynamic Factors - Impact Analysis
3.6. Global Livestock Pharmaceuticals Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.7. Global Livestock Pharmaceuticals Market – Recent Product Introductions

4. Global Livestock Pharmaceuticals Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. Global Livestock Pharmaceuticals Market, By Drug Class, 2012 – 2016 and Forecast, 2017 – 2023
5.1. Vaccines
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Antivirals
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Antibiotics
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Parasiticides
5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Anti-Inflammatory Drugs
5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis

Continue…….

Buy 1-User PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2753949

For more information or any query mail at sales@wiseguyreports.com

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Office No.528,Amanora Chambers,Magarpatta Road,Hadapsar,Pune-411028.

This release was published on openPR.